U.S. flag

An official website of the United States government

Filters

See more specimen types...

Other countries

Results: 21 to 40 of 49

Tests names and labsConditionsGenes, analytes, and microbesMethods

Inherited Cancer Panel

Dhiti Omics Technologies Private Ltd
India
13584
  • C Sequence analysis of the entire coding region

Hereditary pediatric cancer panel. NGS panel of 71 genes.

Genologica Medica
Spain
15871
  • C Sequence analysis of the entire coding region

Nephrotic syndrome panel. 36-gene NGS panel.

Genologica Medica
Spain
4936
  • C Sequence analysis of the entire coding region

Panel of premature ovarian failure. NGS panel of 15 genes.

Genologica Medica
Spain
5015
  • C Sequence analysis of the entire coding region

Hereditary kidney cancer panel. NGS panel of 26 genes.

Genologica Medica
Spain
7426
  • C Sequence analysis of the entire coding region

Genital Abnormalities / Sex Development Disorders Panel

Genologica Medica
Spain
9549
  • C Sequence analysis of the entire coding region

Renal malformation panel. NGS panel of 22 genes.

Genologica Medica
Spain
4422
  • C Sequence analysis of the entire coding region

Preventive 59

Genologica Medica
Spain
17259
  • C Sequence analysis of the entire coding region

Wilms Tumor (WT1 Gene) Sequence Analysis

Duzen Laboratories Duzen BBAGUAS
Turkey
41
  • C Sequence analysis of the entire coding region

WT1

Institute for Human Genetics University Medical Center Freiburg
Germany
61
  • C Sequence analysis of the entire coding region

Nephrotic Syndrome

Asper Biogene Asper Biogene LLC
Estonia
2015
  • C Sequence analysis of the entire coding region

Comprehensive Glomerular Proteinuria NGS Panel

Fulgent Genetics
United States
18276
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Denys-Drash Syndrome (WT1 Single Gene Test)

Fulgent Genetics
United States
81
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Frasier Syndrome (WT1 Single Gene Test)

Fulgent Genetics
United States
81
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

ACMG Secondary Findings (Medically Actionable Genes, Including Cardio and Cancer) NGS Panel

Fulgent Genetics
United States
17759
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Renal Malformation NGS Panel

Fulgent Genetics
United States
4315
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Focal Glomerulonephrosis NGS Panel

Fulgent Genetics
United States
157
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Comprehensive Hereditary Cancer Panel

Baylor Genetics
United States
13261
  • E Sequence analysis of select exons

Hereditary Renal Cancer Panel

Baylor Genetics
United States
4113
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons

Invitae WT1-Related Disorders Test

Invitae
United States
81
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

Results: 21 to 40 of 49

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.